To maximize the drugability potential, we target approaches to improve clinical benefits based on reverse translational science and emerging biology of the tumor microenvironment.
(Reverse)Translational Science
Identification of patients' unmet needs, novel targets, pathways, and mechanisms.
Drug Discovery & Development
Validation of target, mechanism of action, and proof of concept, and development of novel engager with high potency and good safety profile.
Immunotherapy
Boosting of anti-tumor immunity to fight against cancer.
为了更好的呈现效果，移动端请竖屏浏览
